20846-52-0 Usage
General Description
2-Chloroethanimidamide hydrochloride is a chemical compound with the molecular formula C2H6Cl2N2, and it is also known as amino-chloroacetonitrile hydrochloride. It is a water-soluble solid that is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is a versatile reagent that is used in various organic reactions, and it can also function as a precursor for the production of other chemical compounds. 2-CHLOROETHANIMIDAMIDE HYDROCHLORIDE is known for its ability to undergo nucleophilic substitution reactions and is commonly used in the production of heterocyclic compounds. Overall, 2-Chloroethanimidamide hydrochloride plays a significant role in the chemical industry as a valuable building block in the synthesis of various important chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 20846-52-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,8,4 and 6 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 20846-52:
(7*2)+(6*0)+(5*8)+(4*4)+(3*6)+(2*5)+(1*2)=100
100 % 10 = 0
So 20846-52-0 is a valid CAS Registry Number.
20846-52-0Relevant articles and documents
-
Schaefer,F.C.,Peters,G.A.
, p. 412 - 418 (1961)
-
4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS
-
Page/Page column 28, (2013/03/26)
The present invention provides for compounds of formula (I) wherein R1 and R2 are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as fo
NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS
-
Page/Page column 43, (2013/03/26)
The present invention provides for compounds of formula (I), wherein R1-R5 and L are defined herein. The present invention also provides for pharmaceutical compositions and combinations comprising a compound of formula (I) as well as for the use of such compounds as tankyrase inhibitors and in the treatment of Wnt signaling and tankyrase 1 and 2 signaling related disorders which include, but are not limited to, cancer.